Results
|
|
41.
|
|
|
|
42.
|
Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells. [electronic resource] by
- van der Vliet, Hans J J
- Molling, Johan W
- Nishi, Nobusuke
- Masterson, Allan J
- Kölgen, Wendy
- Porcelli, Steven A
- van den Eertwegh, Alfons J M
- von Blomberg, B Mary E
- Pinedo, Herbert M
- Giaccone, Giuseppe
- Scheper, Rik J
Producer: 20030813
In:
Cancer research vol. 63
Availability: No items available.
|
|
|
43.
|
Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis. [electronic resource] by
- Vosslamber, Saskia
- Raterman, Hennie G
- van der Pouw Kraan, Tineke C T M
- Schreurs, Marco W J
- von Blomberg, B Mary E
- Nurmohamed, Michael T
- Lems, Willem F
- Dijkmans, Ben A C
- Voskuyl, Alexandre E
- Verweij, Cornelis L
Producer: 20110713
In:
Annals of the rheumatic diseases vol. 70
Availability: No items available.
|
|
|
44.
|
Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide. [electronic resource] by
- Bontkes, Hetty J
- Moreno, María
- Hangalapura, Basav
- Lindenberg, Jelle J
- de Groot, Jan
- Lougheed, Sinéad
- van der Vliet, Hans J J
- van den Eertwegh, Alfons J M
- de Gruijl, Tanja D
- von Blomberg, B Mary E
- Scheper, Rik J
Producer: 20100830
In:
Clinical immunology (Orlando, Fla.) vol. 136
Availability: No items available.
|
|
|
45.
|
Origin and immunophenotype of aberrant IEL in RCDII patients. [electronic resource] by
- Tack, Greetje J
- van Wanrooij, Roy L J
- Langerak, Anton W
- Tjon, Jennifer M L
- von Blomberg, B Mary E
- Heideman, Danielle A M
- van Bergen, Jeroen
- Koning, Frits
- Bouma, Gerd
- Mulder, Chris J J
- Schreurs, Marco W J
Producer: 20120501
In:
Molecular immunology vol. 50
Availability: No items available.
|
|
|
46.
|
Decreased circulating iNKT cell numbers in refractory coeliac disease. [electronic resource] by
- Bernardo, David
- van Hoogstraten, Ingrid M W
- Verbeek, Wieke H M
- Peña, A Salvador
- Mearin, M Luisa
- Arranz, Eduardo
- Garrote, José Antonio
- Scheper, Rik J
- Schreurs, Marco W J
- Bontkes, Hetty J
- Mulder, Chris J J
- von Blomberg, B Mary E
Producer: 20080228
In:
Clinical immunology (Orlando, Fla.) vol. 126
Availability: No items available.
|
|
|
47.
|
Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection. [electronic resource] by
- van der Vliet, Hans J J
- van Vonderen, Marit G A
- Molling, Johan W
- Bontkes, Hetty J
- Reijm, Martine
- Reiss, Peter
- van Agtmael, Michiel A
- Danner, Sven A
- van den Eertwegh, Alfons J M
- von Blomberg, B Mary E
- Scheper, Rik J
Producer: 20061213
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 177
Availability: No items available.
|
|
|
48.
|
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. [electronic resource] by
- Giaccone, Giuseppe
- Punt, Cornelis J A
- Ando, Yoshitaka
- Ruijter, Rita
- Nishi, Nobusuke
- Peters, Marlies
- von Blomberg, B Mary E
- Scheper, Rik J
- van der Vliet, Hans J J
- van den Eertwegh, Alfons J M
- Roelvink, Marja
- Beijnen, Jos
- Zwierzina, Heinz
- Pinedo, Herbert M
Producer: 20030121
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 8
Availability: No items available.
|
|
|
49.
|
Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load. [electronic resource] by
- Molling, Johan W
- Kölgen, Wendy
- van der Vliet, Hans J J
- Boomsma, Martijn F
- Kruizenga, Hinke
- Smorenburg, Carolien H
- Molenkamp, Barbara G
- Langendijk, Johannes A
- Leemans, C René
- von Blomberg, B Mary E
- Scheper, Rik J
- van den Eertwegh, Alfons J M
Producer: 20050708
In:
International journal of cancer vol. 116
Availability: No items available.
|
|
|
50.
|
Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C. [electronic resource] by
- Veldt, Bart J
- van der Vliet, Hans J J
- von Blomberg, B Mary E
- van Vlierberghe, Hans
- Gerken, Guido
- Nishi, Nobusuke
- Hayashi, Kunihiko
- Scheper, Rik J
- de Knegt, Robert J
- van den Eertwegh, Alfons J M
- Janssen, Harry L A
- van Nieuwkerk, Carin M J
Producer: 20071203
In:
Journal of hepatology vol. 47
Availability: No items available.
|
|
|
51.
|
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study. [electronic resource] by
- Tack, Greetje J
- van de Water, Jolanda M W
- Bruins, Maaike J
- Kooy-Winkelaar, Engelina M C
- van Bergen, Jeroen
- Bonnet, Petra
- Vreugdenhil, Anita C E
- Korponay-Szabo, Ilma
- Edens, Luppo
- von Blomberg, B Mary E
- Schreurs, Marco W J
- Mulder, Chris J
- Koning, Frits
Producer: 20140313
In:
World journal of gastroenterology vol. 19
Availability: No items available.
|
|
|
52.
|
Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. [electronic resource] by
- van der Vliet, Hans J J
- von Blomberg, B Mary E
- Hazenberg, Mette D
- Nishi, Nobusuke
- Otto, Sigrid A
- van Benthem, Birgit H
- Prins, Maria
- Claessen, Frans A
- van den Eertwegh, Alfons J M
- Giaccone, Giuseppe
- Miedema, Frank
- Scheper, Rik J
- Pinedo, Herbert M
Producer: 20020212
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 168
Availability: No items available.
|
|
|
53.
|
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. [electronic resource] by
- van der Vliet, Hans J J
- Molling, Johan W
- von Blomberg, B Mary E
- Kölgen, Wendy
- Stam, Anita G
- de Gruijl, Tanja D
- Mulder, Chris J
- Janssen, Harry L A
- Nishi, Nobusuke
- van den Eertwegh, Alfons J M
- Scheper, Rik J
- van Nieuwkerk, Carin J M
Producer: 20050308
In:
Clinical immunology (Orlando, Fla.) vol. 114
Availability: No items available.
|
|
|
54.
|
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment. [electronic resource] by
- Santegoets, Saskia J A M
- Stam, Anita G M
- Lougheed, Sinéad M
- Gall, Helen
- Scholten, Petra E T
- Reijm, Martine
- Jooss, Karin
- Sacks, Natalie
- Hege, Kristen
- Lowy, Israel
- Cuillerot, Jean-Marie
- von Blomberg, B Mary E
- Scheper, Rik J
- van den Eertwegh, Alfons J M
- Gerritsen, Winald R
- de Gruijl, Tanja D
Producer: 20130412
In:
Cancer immunology, immunotherapy : CII vol. 62
Availability: No items available.
|
|
|
55.
|
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. [electronic resource] by
- van den Eertwegh, Alfons J M
- Versluis, Jurjen
- van den Berg, H Pieter
- Santegoets, Saskia J A M
- van Moorselaar, R Jeroen A
- van der Sluis, Tim M
- Gall, Helen E
- Harding, Thomas C
- Jooss, Karin
- Lowy, Israel
- Pinedo, Herbert M
- Scheper, Rik J
- Stam, Anita G M
- von Blomberg, B Mary E
- de Gruijl, Tanja D
- Hege, Kristen
- Sacks, Natalie
- Gerritsen, Winald R
Producer: 20120626
In:
The Lancet. Oncology vol. 13
Availability: No items available.
|